XOMA Corporation Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (USD $) In Thousands, except Share data, unless otherwise specified	Common Stock [Member]	Paid-In Capital [Member]	Accumulated Comprehensive Income [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2011	$ 263	$ 900,801	$ 0	$ (886,053)	$ 15,011us-gaap_StockholdersEquity
Balance (in shares) at Dec. 31, 2011	35,107,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options, contributions to 401(k) and incentive plans	8	1,323	0	0	1,331
Exercise of stock options, contributions to 401(k) and incentive plans (in shares)	1,089,000
Release of restricted stock units	0	0	0	0	0xoma_ReleaseOfRestrictedStockUnits
Release of restricted stock units (in shares)	397,000
Stock-based compensation expense	0	4,284	0	0	4,284
Sale of shares of common stock	340	75,960	0	0	76,300
Sale of shares of common stock (in shares)	45,288,000
Issuance of warrants	0	(6,335)	0	0	(6,335)
Exercise of warrants	4	1,929	0	0	1,933
Exercise of warrants (in shares)	566,000
Net loss	0	0	0	(71,065)	(71,065)us-gaap_NetIncomeLoss
Other comprehensive income (loss)	0	0	8	0	8us-gaap_ComprehensiveIncomeNetOfTax
Balance at Dec. 31, 2012	615	977,962	8	(957,118)	21,467us-gaap_StockholdersEquity
Balance (in shares) at Dec. 31, 2012	82,447,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options, contributions to 401(k) and incentive plans	7	2,213	0	0	2,220
Exercise of stock options, contributions to 401(k) and incentive plans (in shares)	933,000
Release of restricted stock units	6	(6)	0	0	0xoma_ReleaseOfRestrictedStockUnits
Release of restricted stock units (in shares)	801,000
Stock-based compensation expense	0	5,099	0	0	5,099
Sale of shares of common stock	147	82,799	0	0	82,946
Sale of shares of common stock (in shares)	19,661,000
Exercise of warrants	12	8,336	0	0	8,348
Exercise of warrants (in shares)	1,544,000
Net loss	0	0	0	(124,058)	(124,058)us-gaap_NetIncomeLoss
Other comprehensive income (loss)	0	0	(9)	0	(9)us-gaap_ComprehensiveIncomeNetOfTax
Balance at Dec. 31, 2013	787	1,076,403	(1)	(1,081,176)	(3,987)us-gaap_StockholdersEquity
Balance (in shares) at Dec. 31, 2013	105,386,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options, contributions to 401(k) and incentive plans	11	4,515	0	0	4,526
Exercise of stock options, contributions to 401(k) and incentive plans (in shares)	1,065,000
Release of restricted stock units	7	(7)	0	0	0xoma_ReleaseOfRestrictedStockUnits
Release of restricted stock units (in shares)	981,000
Stock-based compensation expense	0	10,772	0	0	10,772
Sale of shares of common stock	61	37,725	0	0	37,786
Sale of shares of common stock (in shares)	8,097,000
Issuance of warrants		(10,258)			(10,258)
Exercise of warrants	3	2,557	0	0	2,560
Exercise of warrants (in shares)	363,000
Net loss	0	0	0	(38,301)	(38,301)us-gaap_NetIncomeLoss
Other comprehensive income (loss)	0	0	1	0	1us-gaap_ComprehensiveIncomeNetOfTax
Balance at Dec. 31, 2014	$ 869	$ 1,121,707	$ 0	$ (1,119,477)	$ 3,099us-gaap_StockholdersEquity
Balance (in shares) at Dec. 31, 2014	115,892,000